Study aiming at reducing the risk of diabetes using Omega-3 Supplementation
The IRCM clinic is looking for adults to participate in a clinical study aiming at the prevention of type II diabetes. The project examines the effects of omega-3 supplements on inhibiting newly discovered risk factors linked to the development of type II diabetes. Participants will benefit from a medical examination that consists of tests that are only available in clinical research. This is in addition to obtaining relevant information on their general health, including the risk to develop type II diabetes, body composition (muscle mass, fat tissue and bone density), number of calories burned at rest, etc.
Participant will receive financial compensation for their time and expenses. The project takes place under the supervision of Dr. May Faraj, professor in the nutrition department, University of Montreal (UdeM), and director of the research unit on nutrition, lipoproteins and cardiovascular diseases at IRCM.
Man; from 45 to 74 years old
Postmenopausal women; from 45 to 74 years old (without hormone therapy replacement)
With excess body weight (BMI 25-40 kg/m2)
Not a smoker
Not diabetic or have a heart condition
Have normal cholesterol without the use of medication
Be available for the duration of the study (10 visits over the span of 33 weeks, including 4 full-day visits)
Have received the first dose of the COVID-19 vaccine at least four weeks ago